We are an agile team that shares a passion for animals and solving complex problems
-
Founder, CEO | LinkedIn
From researching DNA sequencing technologies and stem cells to working in biopharma and investments, Can has demonstrated a keen eye for what drives value in healthcare.
He is a passionate molecular biologist turned entrepreneur, who especially enjoys technology, finance and cats.
Can grew up in Istanbul, Turkey — the cat capital of the world. Kedi means cat in Turkish, and Can named all of his after biologists. He lived in Germany for 13 years.
-
Co-Founder, COO | LinkedIn
From researching drug metabolism and gut microbes to project management and support, Morgan’s strengths emerge in knowledge translation and scientific communication.
She is a computational life scientist and systems thinker at heart, who enjoys art, culture, technology and storytelling.
Morgan grew up in the American Midwest, surrounded by cats and dogs that her family rescued and spoiled. She has made Europe her home for the last decade.
Meet Kedi’s Reason:
Cosmo
In October 2022, our goofy, chirpy, and loving kitten was finally diagnosed with late stage lymphoma. He’d been misdiagnosed with FIP and a common cold before that. Harsh chemotherapy drugs gave us a few more precious months together.
During that time, we couldn’t stop asking why — “why us?” at first, but then: why hasn’t the biotechnology that transformed human pharmaceuticals been applied to animal health (and where else is there room for innovation…)?
We concluded that the absence of advanced treatment options is the main bottleneck to precision veterinary care, far beyond our personal tragedy, and heeded the call to action.
We have since been devoted to bringing the very best that science and technology can offer to veterinary pharmaceutical R&D.
We strive to prevent undue loss of life in other interspecies families.
Together with our Chief Morale Officer, Stella*, it’s our way of honoring Cosmo’s memory.
*Cosmo’s biological mom